Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
The discovery that chemotherapy-induced cognitive impairment, or “chemobrain,” may be linked to an excess of calcium inside cells opens new avenues for potential therapies. This breakthrough could lead to treatments that restore cognition in patients experiencing these symptoms.
Neurology November 1st 2023
Oncology News Central (ONC)
This recent study suggests that systemic treatment with chemotherapy plus immunotherapy may allow patients with muscle-invasive bladder cancer (MIBC) to avoid radical cystectomy.
Oncology, Medical October 23rd 2023
ACP Internist
Test your knowledge and clinical acumen with this quiz, featuring a case study on chemotherapy regimens for metastatic adenocarcinoma of the colon.
Gastroenterology October 19th 2023
Cancer Therapy Advisor
Explore how high-dose hyperfractionated thoracic radiotherapy is setting new standards in LS-SCLC treatment.
Oncology, Medical October 17th 2023
Recent findings from the MARS 2 trial challenge traditional treatment protocols for mesothelioma, indicating that chemotherapy alone may offer improved outcomes over combined surgical approaches. Discover why experts are re-evaluating long-standing surgical treatments.
Oncology, Medical September 25th 2023
Dana-Farber Cancer Institute
Discover how the FLAURA2 trial’s findings on combination therapy could revolutionize initial treatment plans for NSCLC patients with EGFR mutations. Learn more about the significant extension in progression-free survival and its potential clinical implications.